The global cell and gene therapy (CGT) clinical trials market size was estimated at USD 10.75 billion in 2024 and is projected to reach USD 39.41 billion by 2033, growing at a CAGR of 15.58% from 2025 to 2033. This strong growth outlook reflects the rapid evolution of advanced therapeutic modalities aimed at addressing complex and previously untreatable diseases. The market is being driven by...